「more」の検索結果
30件：16～20件目を表示
-
お知らせ | 千寿製薬株式会社
ntral Retinal Artery Occlusion（PDF） April 23, 2024 Launch and Distribution of “MIEr for NAVIS”（PDF） More
https://www.senju.co.jp/english/news/ -
CEO Message | About Senju | SENJU Pharmaceutical
Since Senju was established in 1947, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&a...
https://www.senju.co.jp/english/about/message.html -
Mytear ALPITATTO EXα | OTC Products, etc. | Products | SENJU Pharmaceutical
no improvement in your symptoms after using this medicine for 2 days. If you use this medicine for more than 2 weeks even after there is an improvement. *Registered salesperson: person who has the li...
https://www.senju.co.jp/english/products/apex.html -
fficacy of the previous formulation while eliminating BAC to avoid such damage and ensure safer and more reliable use. For this approval, a bioequivalence study was conducted on patients with primary ...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf -
Business Activities | About Senju | SENJU Pharmaceutical
e have always taken a pioneering path in ophthalmic pharmaceuticals. In the hope of developing even more original new products for the future, we have begun to take on the challenge of the five senses...
https://www.senju.co.jp/english/about/business/